Hepatic Lipid Metabolism Disorder and Atherosclerosis.

Sen Zhang, Fenfang Hong, Chen Ma, Shulong Yang

Journal: Endocrine, metabolic & immune disorders drug targets 2022;22(6):590-600

PMID: 34931971

Abstract

Lipid metabolism disorder plays a fundamental role in the pathogenesis of atherosclerosis. As the largest metabolic organ of the human body, the liver has a key role in lipid metabolism by influencing fat production, fat decomposition, and the intake and secretion of serum lipoproteins. Numerous clinical and experimental studies have indicated that the dysfunction of hepatic lipid metabolism is closely related to the onset of atherosclerosis. However, the identity and functional role of hepatic lipid metabolism responsible for these associations remain unknown. This review presented that cholesterol synthesis, cholesterol transport, and the metabolism of triglycerides, lipoproteins, and fatty acids are all associated with hepatic lipid metabolism and atherosclerosis. Moreover, the roles of gut microbiota, inflammatory response, and oxidative stress in the pathological association between hepatic lipid metabolism and atherosclerosis are also discussed. This significant evidence strongly supports that hepatic lipid metabolism disorders may increase the risk of atherosclerosis.

Copyright© Bentham Science Publishers; For any queries, please email at [email protected].

Address: Department of Physiology, College of Medicine, Nanchang University, Nanchang, China.; Experimental Center of Pathogen Biology, Nanchang University, Nanchang, China.; Department of Physiology, Fuzhou Medical College, Nanchang University, Fuzhou, Jiangxi 344000, China.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.